Key result
Prostaglandin E1 inhibits ADP-induced platelet aggregation by interfering with ADP binding to specific membrane receptors.
Why the study?
The mechanism by which ADP induces platelet aggregation and how prostaglandin E1 inhibits this process was not fully understood.
Population
Normal human blood platelets in stirred plasma
Comparison
[(14)C]ADP with and without prostaglandin E1
Design
Preclinical experimental study
Follow-up
10-360 seconds
Authors
Loading...
Hypothesis-generating for PGE1 antiplatelet effects; leaves open translation to human thrombosis management.
ADP induces platelet aggregation by binding to specific receptors on the plasma membrane, and prostaglandin E1 inhibits this effect by interfering with ADP binding.
Boullin et al. (1972) studied Normal human blood platelets. Prostaglandin E1 vs. ADP alone was evaluated on Platelet aggregation response and platelet [(14)C]ADP accumulation. Prostaglandin E1 inhibited ADP-induced platelet aggregation and [(14)C]ADP accumulation by interfering with ADP binding to specific receptors on the plasma membrane.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: